NGSX - NeurogesX Incorporated

$7.43 -0.34 | -4.38%
Today's Range: 7.42 - 7.89
NGSX Avg. Daily Volume: 92,800
12/15/09 - 1:36 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 7.77
52 Week High 9.20
52 Week Low 1.00
Avg. Daily Vol. (Mil) 0.08
Beta (3 year) 3.11
Share Related Items
Mkt Cap (Mil) 137.09
Shares Out (Mil) 17.64
Float (Mil) 14.89
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.60
Current Ratio 4.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.17
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.15K
Price/Book 32.30
Price/Cash Flow -6.50
Per Share Data
Earnings -1.23
Sales 0.01
Book Value 0.24
Cash Flow -1.20
Business Summary
A biopharmaceutical company, which is focused on developing and commercializing novel pain management therapies.
General Information
2215 Bridgepointe Parkway
Suite 200
San Mateo, CA 94404
www.neurogesx.com
Industry : Drugs
Sector: Health Care
Employees: 42
CEO: Anthony A. DiTonno
Short Interest
Current Month (Mil) 0.51
Previous Month (Mil) 0.28
Short Interest Ratio (Days) 3.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -37.00
Return on Investments -508.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Latest NGSX Headlines

Brokerage Partners

TheStreet Premium Services

All Services